Differential action of anti-emetic drugs on defecation and emesis induced by prostaglandin E2 in the ferret

Eur J Pharmacol. 2006 Aug 21;544(1-3):153-9. doi: 10.1016/j.ejphar.2006.06.034. Epub 2006 Jun 27.

Abstract

In the present studies we investigated the mechanism of action of prostaglandin E2 (1 mg/kg, i.p.) to induce emesis and defecation and/or tenesmus in the ferret. The emesis was antagonized significantly (P<0.05) by ondansetron (0.3 and 1 mg/kg, i.p.) and (+)-(2S,3S)-3-(2-methoxybenzylamino)-2-phenlypiperidine hydrochloride (CP-99,994; 10 mg/kg, i.p.), but neither compound reduced defecations and/or tenesmus, with ondansetron (0.3 mg/kg) actually producing a slight increase (P<0.05). Droperidol (1 and 3 mg/kg), metoclopramide (0.3 and 3 mg/kg), domperidone (0.3 and 3 mg/kg), promethazine (0.3 and 3 mg/kg) and scopolamine (0.3 and 3 mg/kg) failed to reduce prostaglandin E2 induced emesis. However, droperidol (1 and 3 mg/kg) and scopolamine (0.3 and 3 mg/kg) reduced significantly the defecatory and/or tenesmus response (P<0.05). Bilateral abdominal vagotomy was ineffective to reduce emesis and defecations and/or tenesmus. The data suggests that 5-HT3 receptor and NK1 tachykinin receptor antagonists could be useful in the clinic to prevent emesis but not defecations induced by prostaglandin E2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiemetics / pharmacology*
  • Dinoprostone / metabolism*
  • Dopamine Antagonists / metabolism
  • Ferrets
  • Histamine / metabolism
  • Male
  • Receptors, Dopamine / metabolism
  • Receptors, Muscarinic / metabolism
  • Receptors, Serotonin, 5-HT3 / metabolism*
  • Receptors, Tachykinin / antagonists & inhibitors*
  • Vomiting

Substances

  • Antiemetics
  • Dopamine Antagonists
  • Receptors, Dopamine
  • Receptors, Muscarinic
  • Receptors, Serotonin, 5-HT3
  • Receptors, Tachykinin
  • Histamine
  • Dinoprostone